Aldeyra Therapeutics Inc

General ticker "ALDX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $297.5M

Aldeyra Therapeutics Inc follows the US Stock Market performance with the rate: 55.1%.

Estimated limits based on current volatility of 3.4%: low 4.72$, high 5.05$

Factors to consider:

  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.93$, 4.91$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.85$, 4.54$]

Financial Metrics affecting the ALDX estimates:

  • Negative: Non-GAAP EPS, $ of -0.64 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: Operating cash flow per share per price, % of -14.34 <= 2.35
  • Negative: negative Net income
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term ALDX quotes

Long-term ALDX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $56.22MM $62.68MM $42.79MM
Operating Income $-56.22MM $-62.68MM $-42.79MM
Non-Operating Income $-3.11MM $0.66MM $5.25MM
Interest Expense $1.74MM $1.69MM $2.07MM
R&D Expense $44.94MM $47.31MM $29.46MM
Income(Loss) $-59.33MM $-62.02MM $-37.54MM
Profit(Loss) $-59.33MM $-62.02MM $-37.54MM
Stockholders Equity $205.74MM $151.01MM $119.80MM
Inventory $125.00MM $3.24MM $0.00MM
Assets $233.14MM $181.29MM $148.33MM
Operating Cash Flow $-42.56MM $-56.64MM $-30.33MM
Capital expenditure $0.01MM $0.02MM $0.00MM
Investing Cash Flow $-0.01MM $-29.95MM $30.00MM
Financing Cash Flow $194.50MM $1.22MM $-1.27MM
Earnings Per Share* $-1.10 $-1.05 $-0.64

* EPS are Split Adjusted, recent splits may be reflected with a delay.